BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2865258)

  • 21. Metabolism of opioid peptides by cerebral microvascular aminopeptidase M.
    Churchill L; Bausback HH; Gerritsen ME; Ward PE
    Biochim Biophys Acta; 1987 Jan; 923(1):35-41. PubMed ID: 2879569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain.
    Harding JW; Felix D
    Brain Res; 1987 Oct; 424(2):299-304. PubMed ID: 3676828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of low-molecular-weight opioid peptides by vascular plasma membrane aminopeptidase M.
    Bausback HH; Ward PE
    Biochim Biophys Acta; 1986 Jul; 882(3):437-44. PubMed ID: 2873842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines.
    Sekine K; Fujii H; Abe F; Nishikawa K
    Int J Cancer; 2001 Nov; 94(4):485-91. PubMed ID: 11745433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic studies on the aminopeptidase from Aeromonas proteolytica: a two-metal ion mechanism for peptide hydrolysis.
    Chen G; Edwards T; D'souza VM; Holz RC
    Biochemistry; 1997 Apr; 36(14):4278-86. PubMed ID: 9100023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the aminopeptidase from Aeromonas proteolytica by L-leucinethiol: kinetic and spectroscopic characterization of a slow, tight-binding inhibitor-enzyme complex.
    Bienvenue DL; Bennett B; Holz RC
    J Inorg Biochem; 2000 Jan; 78(1):43-54. PubMed ID: 10714704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amastatin and bestatin-induced dipsogenicity in the Sprague-Dawley rat.
    Quirk WS; Harding JW; Wright JW
    Brain Res Bull; 1987 Jul; 19(1):145-7. PubMed ID: 3651838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Degradation of oxytocin by the human placenta: effect of selective inhibitors.
    Mizutani S; Yokosawa H; Tomoda Y
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):76-80. PubMed ID: 1355623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
    Robertson MJ; Cunoosamy MP; Clark KL
    Br J Pharmacol; 1992 May; 106(1):166-72. PubMed ID: 1354540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and characterization of a leucyl aminopeptidase from three pathogenic Leishmania species.
    Morty RE; Morehead J
    J Biol Chem; 2002 Jul; 277(29):26057-65. PubMed ID: 12006595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A membrane-bound alanine aminopeptidase from Acinetobacter calcoaceticus. 3. Inhibition of the enzyme].
    Jahreis G; Aurich H
    Biomed Biochim Acta; 1990; 49(5):339-45. PubMed ID: 1980190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation Into Efficiency of a Novel Glycol Chitosan-Bestatin Conjugate to Protect Thymopoietin Oligopeptides From Enzymatic Degradation.
    Zhang Y; Feng J; Cui L; Zhang Y; Li W; Li C; Shi N; Chen Y; Kong W
    J Pharm Sci; 2016 Feb; 105(2):828-837. PubMed ID: 26173563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of low molecular weight peptides and divalent cations on degradation and binding of angiotensin II.
    Nomura S; Mizutani S; Kurauchi O; Kasugai M; Narita O; Tomoda Y
    Horm Metab Res; 1990 Aug; 22(8):444-8. PubMed ID: 2227802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3-Amino-2-tetralone derivatives: novel potent and selective inhibitors of aminopeptidase-M (EC 3.4.11.2).
    Schalk C; d'Orchymont H; Jauch MF; Tarnus C
    Arch Biochem Biophys; 1994 May; 311(1):42-6. PubMed ID: 7910449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes.
    Orning L; Krivi G; Fitzpatrick FA
    J Biol Chem; 1991 Jan; 266(3):1375-8. PubMed ID: 1846352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Streptomyces griseus aminopeptidase and effects of calcium ions on catalysis and binding--comparisons with the homologous enzyme Aeromonas proteolytica aminopeptidase.
    Papir G; Spungin-Bialik A; Ben-Meir D; Fudim E; Gilboa R; Greenblatt HM; Shoham G; Lessel U; Schomburg D; Ashkenazi R; Blumberg S
    Eur J Biochem; 1998 Dec; 258(2):313-9. PubMed ID: 9874195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin.
    Abhold RH; Sullivan MJ; Wright JW; Harding JW
    J Pharmacol Exp Ther; 1987 Sep; 242(3):957-62. PubMed ID: 3656120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids.
    Wilk S; Thurston LS
    Neuropeptides; 1990 Jul; 16(3):163-8. PubMed ID: 1982017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminopeptidase inhibitor bestatin stimulates microvascular endothelial cell invasion in a fibrin matrix.
    van Hensbergen Y; Broxterman HJ; Peters E; Rana S; Elderkamp YW; van Hinsbergh VW; Koolwijk P
    Thromb Haemost; 2003 Nov; 90(5):921-9. PubMed ID: 14597989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.